Literature DB >> 26859450

Defining the Molecular Alterations of Ampullary Carcinoma.

Jing Tan1, Patrick Tan2, Bin Tean Teh3.   

Abstract

Ampullary carcinomas represent a group of heterogeneous tumors that can be histologically divided into two subtypes with distinct pathogenic and clinical characteristics. Yachida et al. (2016) and Gingras et al. (2016) now report the genomic landscape of ampullary carcinoma, providing insights into molecular drivers with clinical implications for diagnosis and therapeutics.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26859450     DOI: 10.1016/j.ccell.2016.01.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  3 in total

Review 1.  Emerging molecular therapeutic targets for cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  J Hepatol       Date:  2017-04-05       Impact factor: 25.083

2.  Ampullary and pancreatic adenocarcinoma-a comparative study.

Authors:  Marwa Ferchichi; Raja Jouini; Wafa Koubaa; Fatma Khanchel; Imen Helal; Dhafer Hadad; Norsaf Bibani; Aschraf Chadli-Debbiche; Ehsen BenBrahim
Journal:  J Gastrointest Oncol       Date:  2019-04

3.  KRAS, NRAS and BRAF analysis of ampullary adenocarcinoma classified using CK7, CK20, MUC1 and MUC2.

Authors:  Marwa Ferchichi; Raja Jouini; Imen Ayari; Wafa Koubaa; Aschraf Chadli-Debbiche; Ehsen BenBrahim
Journal:  J Gastrointest Oncol       Date:  2018-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.